Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.

Esteva A, Feng J, van der Wal D, Huang SC, Simko JP, DeVries S, Chen E, Schaeffer EM, Morgan TM, Sun Y, Ghorbani A, Naik N, Nathawani D, Socher R, Michalski JM, Roach M 3rd, Pisansky TM, Monson JM, Naz F, Wallace J, Ferguson MJ, Bahary JP, Zou J, Lungren M, Yeung S, Ross AE, NRG Prostate Cancer AI Consortium, Sandler HM, Tran PT, Spratt DE, Pugh S, Feng FY, Mohamad O

Open source

DOI: 10.1038/s41746-022-00613-w
Published: 2022 Jun 8
Container: NPJ digital medicine
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41746-022-00613-w,
  title = {Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.},
  author = {Esteva A and Feng J and van der Wal D and Huang SC and Simko JP and DeVries S and Chen E and Schaeffer EM and Morgan TM and Sun Y and Ghorbani A and Naik N and Nathawani D and Socher R and Michalski JM and Roach M 3rd and Pisansky TM and Monson JM and Naz F and Wallace J and Ferguson MJ and Bahary JP and Zou J and Lungren M and Yeung S and Ross AE and NRG Prostate Cancer AI Consortium and Sandler HM and Tran PT and Spratt DE and Pugh S and Feng FY and Mohamad O},
  year = {2022},
  journal = {NPJ digital medicine},
  doi = {10.1038/s41746-022-00613-w},
  url = {https://doi.org/10.1038/s41746-022-00613-w}
}

RIS

TY  - JOUR
TI  - Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
AU  - Esteva A
AU  - Feng J
AU  - van der Wal D
AU  - Huang SC
AU  - Simko JP
AU  - DeVries S
AU  - Chen E
AU  - Schaeffer EM
AU  - Morgan TM
AU  - Sun Y
AU  - Ghorbani A
AU  - Naik N
AU  - Nathawani D
AU  - Socher R
AU  - Michalski JM
AU  - Roach M 3rd
AU  - Pisansky TM
AU  - Monson JM
AU  - Naz F
AU  - Wallace J
AU  - Ferguson MJ
AU  - Bahary JP
AU  - Zou J
AU  - Lungren M
AU  - Yeung S
AU  - Ross AE
AU  - NRG Prostate Cancer AI Consortium
AU  - Sandler HM
AU  - Tran PT
AU  - Spratt DE
AU  - Pugh S
AU  - Feng FY
AU  - Mohamad O
PY  - 2022
JO  - NPJ digital medicine
DO  - 10.1038/s41746-022-00613-w
UR  - https://doi.org/10.1038/s41746-022-00613-w
ER  -

APA

A, E., J, F., D, V. D. W., SC, H., JP, S., S, D., E, C., EM, S., TM, M., Y, S., A, G., N, N., D, N., R, S., JM, M., 3rd, R. M., TM, P., JM, M., F, N., J, W., MJ, F., JP, B., J, Z., M, L., S, Y., AE, R., Consortium, N. P. C. A., HM, S., PT, T., DE, S., S, P., FY, F., & O, M. (2022). Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.. NPJ digital medicine. https://doi.org/10.1038/s41746-022-00613-w

Source records

pubmed · retrieved 2026-09-26T10:12:20.096Z
europe-pmc · retrieved 2026-09-26T10:12:20.106Z
doaj · retrieved 2026-09-26T10:12:20.096Z